Matches in Wikidata for { <http://www.wikidata.org/entity/Q102071629> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q102071629 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 16ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q102071629 description "article scientifique publié en 2020" @default.
- Q102071629 description "artículu científicu espublizáu en payares de 2020" @default.
- Q102071629 description "scientific article published on 16 November 2020" @default.
- Q102071629 description "wetenschappelijk artikel" @default.
- Q102071629 description "наукова стаття, опублікована 16 листопада 2020" @default.
- Q102071629 name "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 name "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 name "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 type Item @default.
- Q102071629 label "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 label "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 label "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 prefLabel "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 prefLabel "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 prefLabel "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 P1433 Q102071629-1E1B33D4-48E0-4776-9F94-7C8B9466ECE6 @default.
- Q102071629 P1476 Q102071629-E6229ABF-601F-47DF-B86C-BA178D78682C @default.
- Q102071629 P2093 Q102071629-29ECD08F-3E58-4C29-A908-3B5137F54B5C @default.
- Q102071629 P2093 Q102071629-381893DF-7E5B-4507-A5AD-75D2DE186D51 @default.
- Q102071629 P2093 Q102071629-DD2239C1-B1AD-459A-8C8F-F6B977A4FDB6 @default.
- Q102071629 P2860 Q102071629-376247EF-3C5E-45BE-BFDD-984508BB9CC4 @default.
- Q102071629 P2860 Q102071629-553349B6-54B8-4F79-B897-45684440CA9A @default.
- Q102071629 P2860 Q102071629-C79A5CCF-CA95-467E-940E-DEC1BB47D2A3 @default.
- Q102071629 P31 Q102071629-8EA882BB-FF05-4C4F-9C4D-4AA804D35EF1 @default.
- Q102071629 P356 Q102071629-4D6F88CD-8372-4E7A-8E4D-2BCFEC8387DE @default.
- Q102071629 P577 Q102071629-140F61F1-0CB5-4180-8AA4-FA5C76E4ADFC @default.
- Q102071629 P698 Q102071629-24343B9B-A0CE-463D-9D1C-900587BFBDB2 @default.
- Q102071629 P356 ANNUREV-PATHOL-042020-042741 @default.
- Q102071629 P698 33197221 @default.
- Q102071629 P1433 Q15263665 @default.
- Q102071629 P1476 "Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance" @default.
- Q102071629 P2093 "Edgar G Engleman" @default.
- Q102071629 P2093 "Robert Yuan" @default.
- Q102071629 P2093 "Sreya Bagchi" @default.
- Q102071629 P2860 Q24293504 @default.
- Q102071629 P2860 Q28235866 @default.
- Q102071629 P2860 Q29615679 @default.
- Q102071629 P31 Q13442814 @default.
- Q102071629 P356 "10.1146/ANNUREV-PATHOL-042020-042741" @default.
- Q102071629 P577 "2020-11-16T00:00:00Z" @default.
- Q102071629 P698 "33197221" @default.